How should breakthrough pain be managed in opioid-tolerant cancer patients when it occurs?

Study for ELNEC 4: Symptom Management in Palliative Care Test with flashcards and multiple choice questions. Hints and explanations included! Get ready for your exam!

Breakthrough pain in patients on stable opioid therapy is addressed with a rapid-onset, short-acting opioid dose that is calculated from the patient’s current baseline opioid using equianalgesic guidelines, then reassessed after each dose. This approach targets the sudden pain spike quickly and safely, without waiting for long-acting doses to catch up. Rapid-onset options such as transmucosal or intranasal fentanyl or immediate-release morphine/oxycodone are chosen based on the patient’s tolerance, route preference, and prior response. After administration, evaluate how well the dose works and watch for side effects; if pain returns, additional dosing can be given per the plan with ongoing reassessment. If breakthrough pain happens often, consider adjusting the underlying baseline regimen rather than relying solely on repeatedly increasing the basal dose, to balance effective control with safety. Deferring treatment or relying on non-opioids alone is not appropriate for these transient, high-intensity pain episodes.